Senate passes bill requiring detransition services and HIPAA‑compliant reporting; critics raise privacy concerns

The Tennessee Senate approved House Bill 7‑54, a measure that requires clinics offering gender transition services to provide detransition services and directs insurers covering transition care to also cover detransition care. The bill also establishes reporting obligations to the Tennessee Department of Health, with a floor amendment (amendment 4) limiting some public disclosure to avoid identifying individuals in small counties.

Sponsor Senator Taylor said the bill aims to ensure parity of care: “If you offer transition services, you offer the detransition services as well,” he said, adding that the bill’s reporting to the Department of Health would be HIPAA‑compliant and intended to produce aggregated, nonidentifying data.

Opponents warned the reporting requirements are invasive and could chill care. Senator Yarborough said the measure imposes an unusually intrusive reporting regime, requiring physicians to report drugs, dosages, surgical procedures and mental‑health diagnoses to the state and argued that collecting such data about one patient group could set a concerning precedent. "We're singling out this group for a remarkably invasive surveillance protocol," he said.

Senator Campbell emphasized the small numbers involved and argued the legislature should focus on other priorities; Senator Jack Berry called the bill punitive and cautioned about the potential effects on vulnerable people and health‑care access.

Amendment 4, adopted on the floor after the sponsor described discussing the proposal with protesters, prevents publication of county‑level identifiers on the public‑facing website when an aggregation could identify an individual in a small county, and the sponsor said no patient‑identifying information would be revealed.

Final outcome: The bill passed on third and final consideration by a roll‑call vote of 24 Ayes and 7 Nays.

Next steps: The bill will proceed to enrollment; the Department of Health will be responsible for implementing HIPAA‑compliant reporting formats and any aggregated public reporting described in the legislation.

Context: The debate covered medical privacy, insurance coverage parity, the scope of required reporting (whether it applies to all uses of listed drugs or only when prescribed as part of a transition), and whether the state should collect clinical details that are typically treated as confidential.